Trial intelligence / Profile preview

Evira in combination with obesity medications for adolescents

NCT06836284Recruiting

Sponsor
Karolinska Institutet
Start
Feb 2026
Primary completion
Apr 2027
Countries
1
01

Overview

Randomised, open-label trial in obesity (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Change in BMI Standard Deviation Score at 6 months. Started Feb 2026; status: recruiting.

02

Conditions

obesity

Beyond the preview

Go deeper on NCT06836284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06836284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call